Public Profile

Orion

Orion Corporation, commonly referred to as Orion, is a Finnish pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, Orion has established itself as a key player in the pharmaceutical and biotechnology industry, with a strong presence in Europe and beyond. The company focuses on developing innovative medicines and diagnostic products, particularly in the fields of oncology, pain management, and central nervous system disorders. Orion's core offerings include prescription pharmaceuticals and over-the-counter products, distinguished by their commitment to quality and research-driven development. With a robust pipeline of new therapies and a reputation for excellence, Orion has achieved notable milestones, including successful collaborations and a growing international market presence. As a trusted name in healthcare, Orion continues to advance its mission of improving patient outcomes through science and innovation.

DitchCarbon Score

How does Orion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

71

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Orion's score of 71 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Let us know if this data was useful to you

Orion's reported carbon emissions

In 2024, Orion Corporation reported total greenhouse gas emissions of approximately 371,000,000 kg CO2e, with emissions distributed across various scopes: 5,625,000 kg CO2e (Scope 1), 5,330,000 kg CO2e (Scope 2, market-based), and a significant 361,961,000 kg CO2e (Scope 3). This represents a notable increase in Scope 3 emissions compared to previous years, highlighting the challenges in managing indirect emissions. Orion has set ambitious climate commitments, aiming for carbon neutrality in its operations by 2031. The company has established a target to reduce its Scope 1 and 2 greenhouse gas emissions by 70% by 2030, using 2023 as the baseline year. Additionally, Orion is committed to ensuring that 78% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2029. In terms of historical performance, Orion achieved a 69% reduction in Scope 1 and 2 emissions compared to a 2016 baseline, demonstrating significant progress towards its sustainability goals. The company continues to focus on reducing its carbon footprint while addressing the complexities of its supply chain emissions.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

200720082009201320142015201620172018201920202021202220232024
Scope 1
3,740,000
0,000,000
0,000,000
-
0,000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
21,685,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-
-
-
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Orion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Orion is in FI, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Orion is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lundbeck

DK
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Vernalis Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Hikma Pharmaceuticals

GB
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Faes Farma

ES
Pharmaceutical Preparation Manufacturing
Updated about 24 hours ago

Cosmo Pharmaceuticals N.V.

IE
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Recipharm

SE
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers